The VIPCAM Collaboration
The VIPCAM collaboration between the Prevention Group in the MRC Epidemiology Unit, University of Cambridge and Umeå University is centred around data from the Västerbotten Intervention Programme (VIP) which consists of a large population-based cohort of participants in a public health programme on-going since the late 1980’s in Västerbotten County in northern Sweden. Lifestyle behaviour data from questionnaires, objective anthropometric and biochemical data including oral glucose tolerance tests (OGTT) are available at age 30 (until 1995), 40, 50, and 60 for around 100,000 participants at baseline and around 35,000 participants with 10 year follow-up.
These data are also linked to several administrative registers including hospital discharge and cause of death records. Studies in the collaboration focus on investigating the relationship between modifiable lifestyle behaviour risk factors such as BMI, diet and physical activity and diabetes and related conditions on a population-level, and on understanding the impact of the health examinations in VIP as a model of a population-based screening programme for diabetes.
- Long GH, Simmons RK, Norberg M, Wennberg P, Lindahl B, Rolandsson O, Griffin SJ, Weinehall L. Temporal shifts in cardiovascular risk factor distribution. Am J Prev Med. 2014 Feb;46(2):112-21.
- Long GH, Johansson I, Rolandsson O, Wennberg P, Fhärm E, Weinehall L, Griffin SJ, Simmons RK, Norberg M. Healthy behaviours and 10-year incidence of diabetes: a population cohort study. Prev Med. 2015 Feb;71:121-7.
- Feldman AL, Long GH, Johansson I, Weinehall L, Fhärm E, Wennberg P, Norberg M, Griffin SJ, Rolandsson O. Change in lifestyle behaviors and diabetes risk: evidence from a population-based cohort study with 10 year follow-up. Int J Behav Nutr Phys Act. 2017 Mar 29;14(1):39. doi: 10.1186/s12966-017-0489-8
- Feldman AL, Griffin SJ, Ahern AL, Long GH, Weinehall L, Fhärm E, Norberg M, Wennberg P. Impact of weight maintenance and loss on diabetes risk and burden: a population-based study in 33,184 participants. BMC Public Health. 2017 Feb 6;17(1):170. doi: 10.1186/s12889-017-4081-6.
- Feldman AL, Griffin SJ, Fhärm E, Norberg M, Wennberg P, Weinehall L, Rolandsson O. Screening for type 2 diabetes: do screen-detected cases fare better? Diabetologia. 2017 (in press)